Actualités

Symbotic (NasdaqGM:SYM) has signed an agreement with Medline to bring its AI powered warehouse automation system to the healthcare supply chain. This marks the first use of Symbotic's robotics and software platform in healthcare distribution, extending beyond its retail and consumer goods customers. Symbotic enters this Medline agreement with a recent share price of $59.52 and a 5 year return of about 7x. The stock has also posted a 170.5% return over the past year, while year to date...

On CNBC's “Mad Money Lightning Round,” Jim Cramer said Planet Labs PBC is up “way too much” and is just going higher. “We're gonna say, no,” Cramer adds. “We're not going to pay these prices.” Goldman Sachs analyst Anthony Valentini, on April 20, maintained Planet Labs with a Neutral and raised the price target from $18 to $20. Cramer called Symbotic Inc. an automation company and a robotic company. “You are going up against Elon Musk,” he said. “But there's room for both.” Don't Miss: Think You

AMADY vs. SYM: Which Stock Is the Better Value Option?

Recently, Zacks.com users have been paying close attention to SYMBOTIC INC (SYM). This makes it worthwhile to examine what the stock has in store.

In the most recent trading session, Symbotic Inc. (SYM) closed at $62.96, indicating a -3.33% shift from the previous trading day.

What Symbotic’s recent performance means for investors With no single headline event driving attention today, Symbotic (SYM) is drawing interest as the share price sits near US$60.56, alongside strong multi year total returns, as well as rapid reported revenue and net income growth. See our latest analysis for Symbotic. The recent 13.0% 7 day share price return and 15.3% 1 month share price return contrast with a 10.2% 3 month share price decline, while the 1 year total shareholder return of...

Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls